190 related articles for article (PubMed ID: 33455589)
1. Impact of body mass index on intracytoplasmic sperm injection in women with polycystic ovary syndrome.
Kamardi S; Surya IHW; Mahendra INB; Adnyana IP; Suardika A; Tondohusodo N; Sudiman J
Zygote; 2021 Jun; 29(3):229-233. PubMed ID: 33455589
[TBL] [Abstract][Full Text] [Related]
2. Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index.
McCormick B; Thomas M; Maxwell R; Williams D; Aubuchon M
Fertil Steril; 2008 Dec; 90(6):2304-9. PubMed ID: 18191852
[TBL] [Abstract][Full Text] [Related]
3. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
[No Abstract] [Full Text] [Related]
4. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
Sahu B; Ozturk O; Ranierri M; Serhal P
Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140
[TBL] [Abstract][Full Text] [Related]
5. Association between Body Mass Index and Reproductive Outcome in Women with Polycystic Ovary Syndrome Receiving IVF/ICSI-ET.
Zhou H; Zhang D; Luo Z; Yang A; Cui N; Hao G; Wang W
Biomed Res Int; 2020; 2020():6434080. PubMed ID: 32908902
[TBL] [Abstract][Full Text] [Related]
6. [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].
Kdous M; Chaker A; Zhioua A; Zhioua F
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):133-43. PubMed ID: 19179017
[TBL] [Abstract][Full Text] [Related]
7. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
Esinler I; Bayar U; Bozdag G; Yarali H
Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
[TBL] [Abstract][Full Text] [Related]
8. Influencing of serum inflammatory factors on IVF/ICSI outcomes among PCOS patients with different BMI.
He Y; Li R; Yin J; Yang Z; Wang Y; Chen L; Yang S; Qiao J
Front Endocrinol (Lausanne); 2023; 14():1204623. PubMed ID: 37693353
[TBL] [Abstract][Full Text] [Related]
9. Impact of Body Mass Index on Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection Among Polycystic Ovarian Syndrome Patients.
Cui N; Wang H; Wang W; Zhang J; Xu Y; Jiang L; Yang A; Hao G
Cell Physiol Biochem; 2016; 39(5):1723-1734. PubMed ID: 27744442
[TBL] [Abstract][Full Text] [Related]
10. Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome.
Junk SM; Yeap D
Fertil Steril; 2012 Oct; 98(4):888-92. PubMed ID: 22835445
[TBL] [Abstract][Full Text] [Related]
11. Age, body weight and ovarian function affect oocyte size and morphology in non-PCOS patients undergoing intracytoplasmic sperm injection (ICSI).
Weghofer A; Kushnir VA; Darmon SK; Jafri H; Lazzaroni-Tealdi E; Zhang L; Albertini DF; Barad DH; Gleicher N
PLoS One; 2019; 14(10):e0222390. PubMed ID: 31647816
[TBL] [Abstract][Full Text] [Related]
12. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome.
Child TJ; Abdul-Jalil AK; Gulekli B; Tan SL
Fertil Steril; 2001 Nov; 76(5):936-42. PubMed ID: 11704114
[TBL] [Abstract][Full Text] [Related]
13. Effect of body mass index on the outcomes of controlled ovarian hyperstimulation in Chinese women with polycystic ovary syndrome: a multicenter, prospective, observational study.
Sheng Y; Lu G; Liu J; Liang X; Ma Y; Zhang X; Zhang S; Sun Y; Sun Y; Chen W; Fang W; Chen Z
J Assist Reprod Genet; 2017 Jan; 34(1):61-70. PubMed ID: 27817037
[TBL] [Abstract][Full Text] [Related]
14. Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome.
Bailey AP; Hawkins LK; Missmer SA; Correia KF; Yanushpolsky EH
Am J Obstet Gynecol; 2014 Aug; 211(2):163.e1-6. PubMed ID: 24657792
[TBL] [Abstract][Full Text] [Related]
15. Biotechnological and clinical outcome of in vitro fertilization in non-obese patients with polycystic ovarian syndrome.
Ciepiela P; Baczkowski T; Brelik P; Antonowicz A; Safranow K; Kurzawa R
Folia Histochem Cytobiol; 2007; 45 Suppl 1():S65-71. PubMed ID: 18292838
[TBL] [Abstract][Full Text] [Related]
16. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
17. Systematic oxidative stress is not associated with live birth rate in young non-obese patients with polycystic ovarian syndrome undergoing assisted reproduction cycles: A prospective cohort study.
Chen M; Huang X; Liu Y; Lei S; Wu Y; Chen Z; Hong L; Teng X
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():154-161. PubMed ID: 32877771
[TBL] [Abstract][Full Text] [Related]
18. [Oocyte and embryo quality in polycystic ovary syndrome].
Plachot M; Belaisch-Allart J; Mayenga JM; Chouraqui A; Tesquier A; Serkine AM; Boujenah A; Abirached F
Gynecol Obstet Fertil; 2003 Apr; 31(4):350-4. PubMed ID: 12821065
[TBL] [Abstract][Full Text] [Related]
19. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
20. IVF versus ICSI for the fertilization of in-vitro matured human oocytes.
Walls M; Junk S; Ryan JP; Hart R
Reprod Biomed Online; 2012 Dec; 25(6):603-7. PubMed ID: 23063820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
